RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer

Cancer Cell

Volumn 31, Issue 1, 2017, Pages 94-109

  Schneider, Anne T ^a   Gautheron, Jérémie ^a   Feoktistova, Maria ^a   Roderburg, Christoph ^a   Loosen, Sven H ^a   Roy, Sanchari ^a   Benz, Fabian ^a   Schemmer, Peter ^b   Büchler, Markus W ^b   Nachbur, Ueli ^c   Neumann, Ulf P ^a   Tolba, Rene ^a   Luedde, Mark ^d   Zucman Rossi, Jessica ^e   Panayotova Dimitrova, Diana ^a   Leverkus, Martin ^a   Preisinger, Christian ^a   Tacke, Frank ^a   Trautwein, Christian ^a   Longerich, Thomas ^a   Vucur, Mihael ^a   Luedde, Tom ^a   more..

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e Université Paris 13   (France)

Author keywords

apoptosis; caspase 8; cIAP 1; HCC; hepatocarcinogenesis; necroptosis; NF B; RIP1; RIP3; RIPK3

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 8; GLUTAMATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; PROTEASOME; PSMD2 PROTEIN, HUMAN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, HUMAN;

ADENOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL PROLIFERATION; CHOLESTASIS; CONTROLLED STUDY; CYTOKINE RELEASE; DYSPLASIA; ENZYME ACTIVATION; HEP-G2 CELL LINE; HEPATITIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER DEVELOPMENT; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; LIVER NEOPLASMS; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; CASPASE 8; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85009126405     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.11.009     Document Type: Article

References (50)

1. Berger, S.B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 192 (2014), 5476–5480.
2. Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., et al. TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell 17 (2010), 481–496.
3. Bist, P., Leow, S.C., Phua, Q.H., Shu, S., Zhuang, Q., Loh, W.T., Nguyen, T.H., Zhou, J.B., Hooi, S.C., Lim, L.H., Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappaB: implication in breast cancer metastasis. Oncogene 30 (2011), 3174–3185.
4. Bullock, A.N., Degterev, A., Targeting RIPK1,2,3 to combat inflammation. Oncotarget 6 (2015), 34057–34058.
5. Dannappel, M., Vlantis, K., Kumari, S., Polykratis, A., Kim, C., Wachsmuth, L., Eftychi, C., Lin, J., Corona, T., Hermance, N., et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513 (2014), 90–94.
6. Dickens, L.S., Powley, I.R., Hughes, M.A., MacFarlane, M., The ‘complexities’ of life and death: death receptor signalling platforms. Exp. Cell Res. 318 (2012), 1269–1277.
7. Dillon, C.P., Weinlich, R., Rodriguez, D.A., Cripps, J.G., Quarato, G., Gurung, P., Verbist, K.C., Brewer, T.L., Llambi, F., Gong, Y.N., et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157 (2014), 1189–1202.
8. Feldstein, A.E., Gores, G.J., Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front. Biosci. 10 (2005), 3093–3099.
9. Gautheron, J., Vucur, M., Reisinger, F., Cardenas, D.V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A.T., Bartneck, M., Neumann, U.P., et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol. Med. 6 (2014), 1062–1074.
10. Gautheron, J., Vucur, M., Schneider, A.T., Severi, I., Roderburg, C., Roy, S., Bartneck, M., Schrammen, P., Diaz, M.B., Ehling, J., et al. The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance. Nat. Commun., 7, 2016, 11869.
11. Gentle, I.E., Wong, W.W., Evans, J.M., Bankovacki, A., Cook, W.D., Khan, N.R., Nachbur, U., Rickard, J., Anderton, H., Moulin, M., et al. TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. J. Biol. Chem. 286 (2011), 13282–13291.
12. Geraud, C., Mogler, C., Runge, A., Evdokimov, K., Lu, S., Schledzewski, K., Arnold, B., Hammerling, G., Koch, P.S., Breuhahn, K., et al. Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival. Liver Int. 33 (2013), 1428–1440.
13. Gonzalvez, F., Lawrence, D., Yang, B., Yee, S., Pitti, R., Marsters, S., Pham, V.C., Stephan, J.P., Lill, J., Ashkenazi, A., TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol. Cell 48 (2012), 888–899.
14. Grech, A.P., Amesbury, M., Chan, T., Gardam, S., Basten, A., Brink, R., TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 21 (2004), 629–642.
15. Guicciardi, M.E., Mott, J.L., Bronk, S.F., Kurita, S., Fingas, C.D., Gores, G.J., Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Exp. Cell Res. 317 (2011), 107–116.
16. Hoffmann, K., Muller-Butow, V., Franz, C., Hinz, U., Longerich, T., Buchler, M.W., Schemmer, P., Factors predictive of survival after stapler hepatectomy of hepatocellular carcinoma: a multivariate, single-center analysis. Anticancer Res. 34 (2014), 767–776.
17. Kaiser, W.J., Daley-Bauer, L.P., Thapa, R.J., Mandal, P., Berger, S.B., Huang, C., Sundararajan, A., Guo, H., Roback, L., Speck, S.H., et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc. Natl. Acad. Sci. USA 111 (2014), 7753–7758.
18. Karl, I., Jossberger-Werner, M., Schmidt, N., Horn, S., Goebeler, M., Leverkus, M., Wajant, H., Giner, T., TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis. Cell Death Dis., 5, 2014, e1444.
19. Kellendonk, C., Opherk, C., Anlag, K., Schutz, G., Tronche, F., Hepatocyte-specific expression of Cre recombinase. Genesis 26 (2000), 151–153.
20. Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z., Leder, P., The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8 (1998), 297–303.
21. Kondylis, V., Polykratis, A., Ehlken, H., Ochoa-Callejero, L., Straub, B.K., Krishna-Subramanian, S., Van, T.M., Curth, H.M., Heise, N., Weih, F., et al. NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis. Cancer Cell 28 (2015), 582–598.
22. Koppe, C., Verheugd, P., Gautheron, J., Reisinger, F., Kreggenwinkel, K., Roderburg, C., Quagliata, L., Terracciano, L., Gassler, N., Tolba, R.H., et al. IkappaB kinasealpha/beta control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. Hepatology 64 (2016), 1217–1231.
23. Kranz, A., Fu, J., Duerschke, K., Weidlich, S., Naumann, R., Stewart, A.F., Anastassiadis, K., An improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase. Genesis 48 (2010), 512–520.
24. Lamkanfi, M., D'Hondt, K., Vande Walle, L., van Gurp, M., Denecker, G., Demeulemeester, J., Kalai, M., Declercq, W., Saelens, X., Vandenabeele, P., A novel caspase-2 complex containing TRAF2 and RIP1. J. Biol. Chem. 280 (2005), 6923–6932.
25. Linkermann, A., Green, D.R., Necroptosis. N. Engl. J. Med. 370 (2014), 455–465.
26. Liu, X.Y., Lai, F., Yan, X.G., Jiang, C.C., Guo, S.T., Wang, C.Y., Croft, A., Tseng, H.Y., Wilmott, J.S., Scolyer, R.A., et al. RIP1 kinase is an oncogenic driver in melanoma. Cancer Res. 75 (2015), 1736–1748.
27. Luan, Q., Jin, L., Jiang, C.C., Tay, K.H., Lai, F., Liu, X.Y., Liu, Y.L., Guo, S.T., Li, C.Y., Yan, X.G., et al. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy. Autophagy 11 (2015), 975–994.
28. Luedde, T., Schwabe, R.F., NF-kappaB in the liver–linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 8 (2011), 108–118.
29. Luedde, T., Heinrichsdorff, J., De Lorenzi, R., De Vos, R., Roskams, T., Pasparakis, M., IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc. Natl. Acad. Sci. USA 105 (2008), 9733–9738.
30. Luedde, T., Kaplowitz, N., Schwabe, R.F., Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147 (2014), 765–783.e4.
31. Maeda, S., Chang, L., Li, Z.W., Luo, J.L., Leffert, H., Karin, M., IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity 19 (2003), 725–737.
32. Newton, K., Sun, X., Dixit, V.M., Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell Biol. 24 (2004), 1464–1469.
33. Ofengeim, D., Yuan, J., Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat. Rev. Mol. Cell Biol. 14 (2013), 727–736.
34. Pasparakis, M., Making gene-modified mice. Ernst Schering Res. Found. Workshop, 2005, 1–26.
35. Pasparakis, M., Vandenabeele, P., Necroptosis and its role in inflammation. Nature 517 (2015), 311–320.
36. Petersen, S.L., Chen, T.T., Lawrence, D.A., Marsters, S.A., Gonzalvez, F., Ashkenazi, A., TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ. 22 (2015), 1846–1857.
37. Rickard, J.A., O'Donnell, J.A., Evans, J.M., Lalaoui, N., Poh, A.R., Rogers, T., Vince, J.E., Lawlor, K.E., Ninnis, R.L., Anderton, H., et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157 (2014), 1175–1188.
38. Salmena, L., Lemmers, B., Hakem, A., Matysiak-Zablocki, E., Murakami, K., Au, P.Y., Berry, D.M., Tamblyn, L., Shehabeldin, A., Migon, E., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17 (2003), 883–895.
39. Schneider, A.T., Gautheron, J., Tacke, F., Vucur, M., Luedde, T., Receptor interacting protein kinase-1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity. Hepatology 64 (2015), 306–308.
40. Schulze, K., Imbeaud, S., Letouze, E., Alexandrov, L.B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47 (2015), 505–511.
41. Takahashi, N., Duprez, L., Grootjans, S., Cauwels, A., Nerinckx, W., DuHadaway, J.B., Goossens, V., Roelandt, R., Van Hauwermeiren, F., Libert, C., et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis., 3, 2012, e437.
42. Takahashi, N., Vereecke, L., Bertrand, M.J., Duprez, L., Berger, S.B., Divert, T., Goncalves, A., Sze, M., Gilbert, B., Kourula, S., et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513 (2014), 95–99.
43. Takeuchi, M., Rothe, M., Goeddel, D.V., Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271 (1996), 19935–19942.
44. Vince, J.E., Chau, D., Callus, B., Wong, W.W., Hawkins, C.J., Schneider, P., McKinlay, M., Benetatos, C.A., Condon, S.M., Chunduru, S.K., et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J. Cell Biol. 182 (2008), 171–184.
45. Vucur, M., Roderburg, C., Bettermann, K., Tacke, F., Heikenwalder, M., Trautwein, C., Luedde, T., Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?. Oncotarget 1 (2010), 373–378.
46. Vucur, M., Reisinger, F., Gautheron, J., Janssen, J., Roderburg, C., Cardenas, D.V., Kreggenwinkel, K., Koppe, C., Hammerich, L., Hakem, R., et al. RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell Rep. 4 (2013), 776–790.
47. Wang, P., Zhang, J., Bellail, A., Jiang, W., Hugh, J., Kneteman, N.M., Hao, C., Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Cell Signal. 19 (2007), 2237–2246.
48. Weinlich, R., Green, D.R., The two faces of receptor interacting protein kinase-1. Mol. Cell 56 (2014), 469–480.
49. Wilson, N.S., Dixit, V., Ashkenazi, A., Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10 (2009), 348–355.
50. Wong, W.W., Gentle, I.E., Nachbur, U., Anderton, H., Vaux, D.L., Silke, J., RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ. 17 (2010), 482–487.